Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Goldfarb

Surgery of the Hand Saint Louis, MO Medical Doctor

NPI 1871511352 CMS profile 129676

4921 Parkview Pl, Dept Orthopaedic Surgery, Ste 6A/6B/12A, Saint Louis, MO 63110

Open in the dashboard

General payments

$120,670

111 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Goldfarb of Saint Louis, MO is reported in the CMS Open Payments database as having received $120,670 across 111 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,560 35
2024 General $10,000 4
2023 General $19,904 17
2022 General $12,096 14
2021 General $10,976 10
2020 General $6,744 4
2019 General $32,390 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Goldfarb
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Charles Goldfarb were reported at $28,560. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.

Show as a table
Year Charles Goldfarb Surgery of the Hand median Middle half National median
2019 $32,390 $369 $108–$1,516 $163
2020 $6,744 $153 $56–$898 $114
2021 $10,976 $261 $84–$1,296 $132
2022 $12,096 $313 $103–$1,562 $149
2023 $19,904 $241 $95–$876 $160
2024 $10,000 $236 $84–$890 $164
2025 $28,560 $288 $115–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Acumed LLC $78,041 80 payments
  2. Checkpoint Surgical, Inc $20,475 6 payments
  3. Arthrex, Inc. $19,533 18 payments
  4. Elite Orthopedics, LLC $2,621 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $53,330 13 payments
  2. Consulting Fee $49,775 24 payments
  3. Travel and Lodging $7,106 38 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $6,425 2 payments
  5. Education $2,500 2 payments
  6. Food and Beverage $1,533 32 payments
Products named General payments · program years 2019–2025
  1. ACUMED Elbow $36,421 40 payments
  2. Checkpoint Stimulators $20,475 6 payments
  3. Acutrak Headless Compression Screw System $18,961 10 payments
  4. Acu-Loc Wrist Plating System $18,961 10 payments
  5. Hand Fracture System $17,253 9 payments
  6. Total Wrist Fusion Plating System $11,688 5 payments
  7. Osteotomy System $11,688 5 payments
  8. ACUMED Hand & Wrist $9,477 9 payments
  9. ACUMED Hand & Wrist $8,552 4 payments
  10. ACUMED Hand & Wrist $8,397 3 payments
  11. Other $12,720 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

24

Median for Hand Surgery: 118

Drug cost

$100

Median for Hand Surgery: $615

Branded share of claims

100%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $100

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$28,602

Of which drugs: $216

Medicare patients

77

Average age 71

Services billed

1,718

37 women, 40 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 66%
High blood pressure 60%
Depression 26%
Ischemic heart disease 22%
Cancer 16%
Osteoporosis 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 25 1,460 $125
Injection, methylprednisolone acetate, 40 mg J1030 Office 13 21 $91

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

111 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record